Development of risk profiles for systemic lupus erythematosus

Nancy J. Olsen, Amy E. Wandstrat, David R. Karp

Research output: Contribution to journalArticle

Abstract

Early diagnosis of autoimmune disease is a goal of ongoing research in multiple areas. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that causes significant morbidity and premature mortality. Early diagnosis of lupus prior to the onset of major disease manifestations is currently not reliable, due in large part to the limitations of available tests. Emerging knowledge in human genetics and immunology, assisted by computer-aided bioinformatics analyses, has the potential to contribute significantly to the development of more accurate diagnostic approaches. The identification of patients in the early stages of disease, or even prior to the onset of any clinically detectable abnormalities, would permit the institution of treatments that have the potential to reverse or prevent organ damage. Potentially useful approaches to detect SLE risk include proteomic detection of autoantibodles, patterns of gene expression by cells in the peripheral blood and genetic polymorphisms detected by single nucleotide changes. While these are being investigated as individual approaches, the greatest strength may lie in the eventual combination of these nonoverlapping measures to develop a profile that can translate to a quantification of lupus risk.

Original languageEnglish (US)
Pages (from-to)507-514
Number of pages8
JournalFuture Rheumatology
Volume2
Issue number5
DOIs
StatePublished - Oct 2007

Fingerprint

Systemic Lupus Erythematosus
Autoimmune Diseases
Early Diagnosis
Premature Mortality
Medical Genetics
Genetic Polymorphisms
Allergy and Immunology
Computational Biology
Proteomics
Nucleotides
Morbidity
Gene Expression
Research
Therapeutics

Keywords

  • Autoantibodies
  • Genetics
  • Lupus

ASJC Scopus subject areas

  • Rheumatology

Cite this

Development of risk profiles for systemic lupus erythematosus. / Olsen, Nancy J.; Wandstrat, Amy E.; Karp, David R.

In: Future Rheumatology, Vol. 2, No. 5, 10.2007, p. 507-514.

Research output: Contribution to journalArticle

Olsen, Nancy J. ; Wandstrat, Amy E. ; Karp, David R. / Development of risk profiles for systemic lupus erythematosus. In: Future Rheumatology. 2007 ; Vol. 2, No. 5. pp. 507-514.
@article{70adb942435c4bdb9abd9ec634bc87d1,
title = "Development of risk profiles for systemic lupus erythematosus",
abstract = "Early diagnosis of autoimmune disease is a goal of ongoing research in multiple areas. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that causes significant morbidity and premature mortality. Early diagnosis of lupus prior to the onset of major disease manifestations is currently not reliable, due in large part to the limitations of available tests. Emerging knowledge in human genetics and immunology, assisted by computer-aided bioinformatics analyses, has the potential to contribute significantly to the development of more accurate diagnostic approaches. The identification of patients in the early stages of disease, or even prior to the onset of any clinically detectable abnormalities, would permit the institution of treatments that have the potential to reverse or prevent organ damage. Potentially useful approaches to detect SLE risk include proteomic detection of autoantibodles, patterns of gene expression by cells in the peripheral blood and genetic polymorphisms detected by single nucleotide changes. While these are being investigated as individual approaches, the greatest strength may lie in the eventual combination of these nonoverlapping measures to develop a profile that can translate to a quantification of lupus risk.",
keywords = "Autoantibodies, Genetics, Lupus",
author = "Olsen, {Nancy J.} and Wandstrat, {Amy E.} and Karp, {David R.}",
year = "2007",
month = "10",
doi = "10.2217/17460816.2.5.507",
language = "English (US)",
volume = "2",
pages = "507--514",
journal = "Future Rheumatology",
issn = "1758-4272",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Development of risk profiles for systemic lupus erythematosus

AU - Olsen, Nancy J.

AU - Wandstrat, Amy E.

AU - Karp, David R.

PY - 2007/10

Y1 - 2007/10

N2 - Early diagnosis of autoimmune disease is a goal of ongoing research in multiple areas. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that causes significant morbidity and premature mortality. Early diagnosis of lupus prior to the onset of major disease manifestations is currently not reliable, due in large part to the limitations of available tests. Emerging knowledge in human genetics and immunology, assisted by computer-aided bioinformatics analyses, has the potential to contribute significantly to the development of more accurate diagnostic approaches. The identification of patients in the early stages of disease, or even prior to the onset of any clinically detectable abnormalities, would permit the institution of treatments that have the potential to reverse or prevent organ damage. Potentially useful approaches to detect SLE risk include proteomic detection of autoantibodles, patterns of gene expression by cells in the peripheral blood and genetic polymorphisms detected by single nucleotide changes. While these are being investigated as individual approaches, the greatest strength may lie in the eventual combination of these nonoverlapping measures to develop a profile that can translate to a quantification of lupus risk.

AB - Early diagnosis of autoimmune disease is a goal of ongoing research in multiple areas. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that causes significant morbidity and premature mortality. Early diagnosis of lupus prior to the onset of major disease manifestations is currently not reliable, due in large part to the limitations of available tests. Emerging knowledge in human genetics and immunology, assisted by computer-aided bioinformatics analyses, has the potential to contribute significantly to the development of more accurate diagnostic approaches. The identification of patients in the early stages of disease, or even prior to the onset of any clinically detectable abnormalities, would permit the institution of treatments that have the potential to reverse or prevent organ damage. Potentially useful approaches to detect SLE risk include proteomic detection of autoantibodles, patterns of gene expression by cells in the peripheral blood and genetic polymorphisms detected by single nucleotide changes. While these are being investigated as individual approaches, the greatest strength may lie in the eventual combination of these nonoverlapping measures to develop a profile that can translate to a quantification of lupus risk.

KW - Autoantibodies

KW - Genetics

KW - Lupus

UR - http://www.scopus.com/inward/record.url?scp=35548969343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548969343&partnerID=8YFLogxK

U2 - 10.2217/17460816.2.5.507

DO - 10.2217/17460816.2.5.507

M3 - Article

AN - SCOPUS:35548969343

VL - 2

SP - 507

EP - 514

JO - Future Rheumatology

JF - Future Rheumatology

SN - 1758-4272

IS - 5

ER -